» Articles » PMID: 28368522

Premature Ovarian Insufficiency: Phenotypic Characterization Within Different Etiologies

Overview
Specialty Endocrinology
Date 2017 Apr 4
PMID 28368522
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Premature ovarian insufficiency (POI) is highly heterogeneous, both in phenotype and etiology. They are not yet clearly stated and correlated.

Objective: To characterize clinical presentations of a large, well-phenotyped cohort of women with POI, and correlate phenotypes with etiologies to draw a comprehensive clinical picture of POI.

Design, Patients, Interventions, And Main Outcome Measures: In this retrospective study, a total of 955 Chinese women with overt POI between 2006 and 2015 were systemically evaluated and analyzed. The phenotypic features, including menstrual characteristics, hormone profiles, ovarian ultrasonography/biopsy, pregnancy/family history, and genetic/autoimmune/iatrogenic etiologies were assessed and further compared within different subgroups.

Results: Among 955 women with POI, 85.97% presented with secondary amenorrhea (SA) and 14.03% with primary amenorrhea (PA). PA represented the most severe ovarian dysfunction and more chromosomal aberrations than SA. The decline of ovarian function in patients with SA progressed quickly. They had shortened reproductive periods (approximately 10 years) and developed amenorrhea within 1 to 2 years after menstrual irregularity. The ovaries were invisible or small, and the presence of follicles (28.43%) was correlated with other good reproductive indicators. Familial patients (12.25%) manifested better ovarian status and fewer chromosomal aberrations than sporadic patients. The etiologies consisted of genetic (13.15%), autoimmune (12.04%), and iatrogenic (7.29%), approximately 68% remaining idiopathic. There were significant differences among different etiologies, with the genetic group representing the most severe phenotype.

Conclusion: Our results regarding distinct phenotypic characteristics and association with different etiologies further confirmed the high heterogeneity of POI. Additional longitudinal clinical studies and pathogenesis research are warranted.

Citing Articles

Human placental mesenchymal stem cells ameliorates premature ovarian insufficiency via modulating gut microbiota and suppressing the inflammation in rats.

Liu S, Wang T, Liu Y, Li Y, Ma J, Hu Q PLoS One. 2025; 20(3):e0313763.

PMID: 40043087 PMC: 11882084. DOI: 10.1371/journal.pone.0313763.


Dietary, metabolic and gut microbiota influences on primary ovarian failure: a two-sample Mendelian randomization study.

Liu X, Lin Z, Zhu K, He R, Jiang Z, Wu H Asia Pac J Clin Nutr. 2025; 34(1):57-65.

PMID: 39828258 PMC: 11742604. DOI: 10.6133/apjcn.202502_34(1).0005.


Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study.

Du Y, Hu Y, Sheng Y, Zhu T, Liu S, Ding H Front Endocrinol (Lausanne). 2024; 15:1417896.

PMID: 39717103 PMC: 11663653. DOI: 10.3389/fendo.2024.1417896.


Novel Loss-of-function Variants of ZP3 Associated with Premature Ovarian Insufficiency.

Zhou L, Yang X, Ren S, Pan Y, Zhou Z, Liu Y Reprod Sci. 2024; 31(12):3919-3928.

PMID: 39485610 DOI: 10.1007/s43032-024-01732-3.


Excess of severe autoimmune diseases in women with premature ovarian insufficiency: a population-based study.

Savukoski S, Silven H, Pesonen P, Pukkala E, Gissler M, Suvanto E Hum Reprod. 2024; 39(11):2601-2607.

PMID: 39322013 PMC: 11532604. DOI: 10.1093/humrep/deae213.